Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Minocycline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for minocycline hydrochloride and what is the scope of minocycline hydrochloride freedom to operate?

Minocycline hydrochloride
is the generic ingredient in six branded drugs marketed by Impax Labs, Medicis, Zydus Worldwide, Mylan Pharms Inc, Triax Pharms, Sun Pharm Inds, Sun Pharm Inds Ltd, Sandoz, Impax Labs Inc, Lupin Ltd, Par Pharm, Dr Reddys Labs Ltd, Lederle, Rempex Pharms Inc, Precision Dermat, Alkem Labs Ltd, Torrent Pharma Inc, Aurobindo Pharma Ltd, Watson Labs, Cnty Line Pharms, Sun Pharm Inds Inc, Aurobindo Pharma, Orapharma, Barr Labs Inc, and Sidmak Labs India, and is included in thirty-two NDAs. There are fourteen patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Minocycline hydrochloride has forty-three patent family members in twenty-two countries.

There are thirteen drug master file entries for minocycline hydrochloride. Forty-nine suppliers are listed for this compound. There are six tentative approvals for this compound.

Summary for Generic Name: minocycline hydrochloride

Tradenames:6
Patents:14
Applicants:25
NDAs:32
Drug Master File Entries: see list13
Suppliers / Packagers: see list49
Bulk Api Vendors: see list45
Clinical Trials: see list1,058
Patent Applications: see list2,387
Therapeutic Class:Dental and Oral Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:minocycline hydrochloride at DailyMed

Pharmacology for Ingredient: minocycline hydrochloride

Ingredient-typeTetracyclines
Drug ClassTetracycline-class Drug

Tentative approvals for MINOCYCLINE HYDROCHLORIDE

Applicant Application No. Form Dosage
► Subscribe► SubscribeTABLET, EXTENDED RELEASE; ORALEQ 65MG BASE
► Subscribe► SubscribeTABLET, EXTENDED RELEASE; ORALEQ 115MG BASE
► Subscribe► SubscribeTABLET, EXTENDED RELEASE; ORALEQ 55MG BASE
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Worldwide
MINOCYCLINE HYDROCHLORIDE
minocycline hydrochloride
CAPSULE;ORAL063009-002Aug 12, 2003ABRXNoNo► Subscribe► Subscribe
Lupin Ltd
MINOCYCLINE HYDROCHLORIDE
minocycline hydrochloride
TABLET, EXTENDED RELEASE;ORAL091424-004Nov 30, 2011ABRXNoNo► Subscribe► Subscribe
Barr Labs Inc
MINOCYCLINE HYDROCHLORIDE
minocycline hydrochloride
TABLET, EXTENDED RELEASE;ORAL065485-002Mar 17, 2009DISCNNoNo► Subscribe► Subscribe
Triax Pharms
MINOCIN
minocycline hydrochloride
CAPSULE;ORAL050315-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds Inc
MINOCYCLINE HYDROCHLORIDE
minocycline hydrochloride
CAPSULE;ORAL090867-003May 13, 2013ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot